LONDON — With the FTSE 100 pushing past 10,000 points for the first time early in 2026 and delivering strong gains driven by defence spending, banking resilience and healthcare innovation, investors are eyeing a select group of blue-chip stocks for potential outperformance this year.

Analysts remain broadly bullish on the UK’s flagship index, forecasting around 14% earnings growth and record dividend payouts of up to £86 billion across constituents. Sectors benefiting from geopolitical tensions, higher interest rates, commodity strength and demographic trends are drawing particular attention as the index eyes further records toward 11,000 or beyond.

Here is a look at 10 FTSE 100 stocks frequently cited by analysts and commentators in early 2026 as strong buys, based on growth potential, valuation, dividends and thematic tailwinds. Selections draw from recurring recommendations across defence, pharmaceuticals, financials, energy and consumer staples, with no single list universally agreed upon but clear consensus themes emerging.

1. BAE Systems (BA.) — Defence giant BAE Systems tops many long-term watchlists as global military spending surges. NATO commitments, European rearmament and ongoing geopolitical risks have fueled order books. Shares have performed strongly, with analysts highlighting consistent revenue visibility and reasonable valuations relative to growth prospects. The stock benefits from both organic expansion and potential acquisitions in the sector.
2. AstraZeneca (AZN) — The UK’s most valuable company by market capitalization at around £230 billion early in the year, AstraZeneca continues to lead on pharmaceutical innovation. Its oncology and rare disease pipelines, combined with strategic collaborations, position it for sustained earnings growth. Healthcare themes tied to ageing populations and medical advances make it a defensive growth play, with strong analyst support.
3. HSBC Holdings (HSBA) — Europe’s largest bank by assets, HSBC has reclaimed top spots in the index on robust Asian exposure and higher net interest income. Banking stocks have rallied to 15-year highs in early 2026 amid rate tailwinds and economic resilience. HSBC offers a compelling mix of dividend yield and international diversification, with analysts noting its undervaluation compared to global peers.
4. Shell (SHEL) — As one of the world’s leading energy majors, Shell provides exposure to oil and gas while advancing in renewables and low-carbon solutions. Energy stocks have supported the FTSE amid commodity price strength. Shell’s substantial dividend, disciplined capital allocation and transition strategy appeal to income and growth investors alike, with recent performance reflecting sector momentum.
5. GSK (GSK) — GlaxoSmithKline has rebounded strongly, reaching multi-year highs on vaccine and specialty medicine momentum. Its pipeline in respiratory, oncology and infectious diseases, plus operational improvements, has driven analyst upgrades. The stock combines growth potential with a solid dividend, fitting both healthcare and income strategies in a higher-rate environment.
6. Barclays (BARC) — The UK-focused lender has seen sharp gains, up over 50% in the prior 12 months into 2026, on improved profitability and share buybacks. Barclays benefits from domestic banking strength and investment banking recovery. Analysts see further upside from cost discipline and potential rate cuts supporting loan demand, making it a high-conviction recovery and value play.
7. Rolls-Royce Holdings (RR.) — Aerospace and defence exposure has propelled Rolls-Royce, with civil aviation recovery and military engine demand boosting results. The company has delivered on efficiency targets and raised guidance, attracting investors seeking cyclical growth. Its transformation story remains compelling despite valuation debates, with strong order intake signaling multi-year tailwinds.
8. Prudential (PRU) — Focused on Asia and emerging markets, Prudential capitalizes on rising wealth and insurance demand in high-growth regions. Analysts highlight its quality management and long-term demographic trends, with the stock trading at attractive valuations. It offers a blend of growth and dividend income, appealing to those betting on global economic rebalancing.
9. Coca-Cola HBC (CCH) — The bottling and beverages group has ranked among the top performers in early 2026, driven by volume growth and pricing power. Strong execution in emerging European and African markets, combined with brand strength, supports earnings resilience. Its forward dividend yield and reasonable multiple make it attractive for consumer staples exposure amid economic uncertainty.
10. Legal & General (LGEN) — Among the highest-yielding FTSE 100 stocks, often exceeding 8-9%, Legal & General delivers reliable income through its insurance and asset management operations. Despite occasional volatility from interest rates and results, its progressive dividend policy and diversified business appeal to income seekers. Analysts view it as a core holding for portfolios prioritizing cash returns in 2026.

The broader context favors these picks. The FTSE 100 outperformed the S&P 500 in 2025 on a local-currency basis, buoyed by “old economy” sectors dismissed by some global investors. Earnings forecasts for 2026 remain constructive, supported by a potentially more dovish Bank of England and resilient corporate balance sheets. Dividend growth is expected to hit records, with the index yield hovering around 3.4%.

Risks persist, however. Global trade tensions, commodity price swings, slower Chinese growth and domestic political factors could weigh on performance. Defence stocks face execution risks on contracts, while banks remain sensitive to interest rate paths and loan impairments. Healthcare faces patent cliffs and regulatory pressures, and energy majors must navigate the energy transition.

Valuations across the FTSE 100 generally appear reasonable compared with U.S. peers, with many stocks trading below historical averages on price-to-earnings or offering attractive dividend cover. This has prompted calls for continued inflows from international investors seeking value and income.

Investment professionals stress diversification and long-term horizons. While the 10 stocks above reflect frequent analyst favorites, individual circumstances vary. Professional advice is recommended, as past performance offers no guarantee of future results and share prices can fall as well as rise.

As of March 24, 2026, the FTSE 100 has posted solid year-to-date gains, with defence, banking and select consumer names leading. Market watchers will monitor upcoming earnings seasons, central bank decisions and geopolitical developments for fresh catalysts.

Investors interested in FTSE 100 exposure can consider individual shares via brokers or low-cost index trackers and ETFs for broader participation. Thematic funds focused on defence, healthcare or dividends have also attracted attention this year.

The UK equity market’s undervaluation narrative, combined with improving fundamentals, continues to underpin optimism. Whether the index reaches new highs or faces volatility, the 10 stocks profiled here embody key themes analysts believe will drive returns in 2026 and beyond.